When does the Besremi (betibeglogene autotemcel) patent expire?
I can’t determine Besremi’s exact patent expiry date from the information provided in your prompt. “Besremi” is a brand name (betibeglogene autotemcel), and patent expiry depends on which specific patent(s) you mean (for example, compound, formulation, method, or use claims) and the country/region (US, EU, UK, etc.).
If you share the jurisdiction (e.g., US or EU) or the patent number/patent family you’re referring to, I can help you interpret the expected expiry.
What does “pharsight” mean in this context?
“Pharsight” can refer to different things depending on the source (for example, a company name or a dataset/tool name used in life-sciences analytics). Without more context, I can’t map it to a specific patent-life or regulatory-history resource.
If you tell me what document/page you saw “Pharsight” on (or paste the text around it), I can explain how it relates to Besremi and whether it’s pointing to specific patent expiry or exclusivity.
What else could block generic competition besides patent expiry?
Even after a patent’s expiration, exclusivity or other legal protections can still delay market entry, depending on the country. These can include regulatory exclusivity periods, pediatric extensions, or data exclusivity rules, and sometimes additional late-life patents.
What information do you need to pinpoint Besremi’s expiry?
To answer precisely, you typically need at least one of the following:
- Country/region (US vs EU vs UK, etc.)
- Patent number(s) or application/publication numbers
- The patent “family” name from the listing you’re looking at
- Whether you mean “patent expiry” or “regulatory exclusivity/marketing exclusivity”
Send the missing details and I’ll calculate/interpret it
Reply with either:
1) the country (US/EU/UK/etc.) plus the patent number(s), or
2) a link/screenshot text that includes the “Pharsight” entry,
and I’ll tell you the relevant expiry date(s) and what they cover.